Figure 4 : Tissue distribution curves of SU2162 after intravenous administration.

(A) Heart (B) Liver (C) Spleen (D) Lung (E) Kidney (F) Brain.

Tan et al.Journal of Pharmaceutical Technology and Drug Research  2014 3:1DOI : 10.7243/2050-120X-3-1